1)Sears SF, Conti JB. Quality of life and psychological functioning of ICD patients. Heart 2002 ; 87 : 488-93.
2)Suzuki T, Shiga T, Kuwahara K, et al. Prevalence and persistence of depression in Patients with Implantable Cardioverter defibrillator 2 years longitudinal study. Pacing Clin Electrophysiol 2010 ; 33 : 1455-61.
3)Suzuki T, Shiga T, Omori H, et al. Depression and outcomes in Japanese patients with Cardiovascular disease : a Prospective Observational Study. Circ J 2016 ; 80 : 2482-8.
4)Poole JE, Johnson GW, Hellkamp AS, et al. Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med 2008 ; 359 : 1009-17.
5)Daubert JP, Zareba W, Cannom DS et al ; MADIT Ⅱ Investigators. Inappropriate implantable cardioverter-defibrillator shocks in MADIT Ⅱ frequency, mechanisms, predictors, and survival impact. J Am Coll Cardiol 2008 ; 51 : 1357-65.
6)Stewart S, Maclntyre K, Hole DJ, et al. More ‘malignant' than cancer? Five-year survival following a first admission for heart failure. Eur J Heart Fail 2001 ; 3 : 315-22.
7)Allen LA, Stevenson LW, Grady KL, et al. Decision Making in Advanced Heart Failure. Circulation 2012 ; 125 : 1928-52.
8)Yancy CW, Jessup M, Bozkurt B, et al. 2013 ACCF/AHA guideline for the management of heart failure : a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2013 ; 62 : e147-239.
9)Nakazawa M, Suzuki T, Shiga T, et al. Deactivation of implantable cardioverter defibrillator in Japanese patients with end stage heart failure. J Arrhythm 2021 ; 37 : 196-202.
10)Trussler A, Alexander B, Campbell D, et al. Deactivation of Implantable Cardioverter Defibrillator in Patients With Terminal Diagnoses. Am J Cardiol 2019 ; 124 : 1064-8.
11)Westerdahl AK, Sutton R, Frykman V, et al. Defibrillator patients should not be denied a peaceful death. Int J Cardiol 2015 ; 182 : 440-6.